National Health Investors (NHI) Expected to Post Earnings on Monday

National Health Investors (NYSE:NHI) is expected to be posting its Q3 2026 results after the market closes on Monday, November 9th. Analysts expect the company to post earnings of $1.18 per share and revenue of $68.53 million for the quarter. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. Investors can find conference call details on the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Tuesday, November 10, 2026 at 10:00 AM ET.

National Health Investors (NYSE:NHI) last announced its earnings results on Monday, August 10th. The real estate investment trust reported $1.19 EPS for the quarter. The business had revenue of $121.32 million for the quarter. National Health Investors had a net margin of 38.56% and a return on equity of 10.89%. The business’s revenue was up 1.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.22 earnings per share. On average, analysts expect National Health Investors to post $4.76 EPS for the current fiscal year and $4.98 EPS for the next fiscal year.

National Health Investors Stock Performance

Shares of NHI stock opened at $67.02 on Monday. The stock has a 50 day simple moving average of $68.10 and a 200-day simple moving average of $76.41. The company has a current ratio of 6.78, a quick ratio of 6.78 and a debt-to-equity ratio of 0.81. The company has a market cap of $3.29 billion, a price-to-earnings ratio of 19.37, a price-to-earnings-growth ratio of 4.27 and a beta of 0.49. National Health Investors has a 12-month low of $63.51 and a 12-month high of $91.38.

National Health Investors Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 6th. Shareholders of record on Wednesday, September 30th will be issued a $0.92 dividend. This represents a $3.68 dividend on an annualized basis and a yield of 5.5%. The ex-dividend date is Wednesday, September 30th. National Health Investors’s dividend payout ratio is 108.67%.

Analysts Set New Price Targets

NHI has been the topic of a number of research analyst reports. National Bank Financial set a $79.00 target price on National Health Investors in a report on Wednesday, September 9th. Huntington assumed coverage on National Health Investors in a research note on Thursday, September 10th. They set an “outperform” rating and a $79.00 price target for the company. Truist Financial cut their price objective on National Health Investors from $81.00 to $80.00 and set a “buy” rating on the stock in a report on Wednesday, September 2nd. BMO Capital Markets reaffirmed an “outperform” rating on shares of National Health Investors in a research note on Wednesday, September 23rd. Finally, Zacks Research upgraded National Health Investors from a “strong sell” rating to a “hold” rating in a report on Tuesday, September 29th. Five research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $81.00.

About National Health Investors

National Health Investors, Inc (NYSE:NHI) is a real estate investment trust that owns and finances income-producing healthcare real estate in the United States. The company primarily focuses on properties serving older adults and patients who require specialized care.

NHI’s portfolio includes independent living communities, assisted living and memory care facilities, skilled nursing facilities, continuing care retirement communities, medical office buildings and other healthcare-related properties.